Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 5,700 shares, a decline of 59.6% from the August 15th total of 14,100 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company's shares are sold short. Currently, 0.0% of the company's shares are sold short. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is presently 0.0 days.
Wall Street Analyst Weigh In
Separately, Zacks Research raised shares of Ascend Wellness to a "strong sell" rating in a research note on Tuesday, August 12th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of "Sell".
Read Our Latest Stock Report on AAWH
Ascend Wellness Trading Down 2.9%
Shares of OTC AAWH traded down $0.02 during trading on Friday, hitting $0.67. 72,026 shares of the company traded hands, compared to its average volume of 165,148. Ascend Wellness has a 1 year low of $0.26 and a 1 year high of $1.02. The company has a 50-day moving average price of $0.55 and a 200-day moving average price of $0.41. The firm has a market capitalization of $136.98 million, a P/E ratio of -1.63 and a beta of 1.17. The company has a quick ratio of 0.80, a current ratio of 1.47 and a debt-to-equity ratio of 2.61.
About Ascend Wellness
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.